NCT05448872View on ClinicalTrials.gov

Real World Experience in Heart Failure With Reduced Ejection Fraction (HFrEF) Patients Treated With sAc/vaL.

CompletedOBSERVATIONAL
Enrollment

924

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
Heart Failure
Interventions
DRUG

Sacubitril/Valsartan

HF patients treated with Sac/Val

Trial Locations (1)

934125

Novartis Investigative Site, Trieste

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY